Xenon Pharmaceuticals Inc. (XENE) insider trading

By person

12 insiders · 30 transactions

3.0×

Ian Mortimer holds only 3.0 times base salary in stock. $2.40M of shares against $786.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ian Mortimer last reported holding, valued at $37.38, the price Common Shares was last bought or sold at on the open market here, on 30 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Ian Mortimer

President & CEO

$1.12M (1)

$20.29M (17) scheduled

−$19.17M

64,223

0.0663%

$2.40M

+40.8%

Christopher John Kenney

Chief Medical Officer

—

$670.26K (4) scheduled

−$670.26K

<0.0001%

$74.76

+100.0%

Steven Gannon

Director

—

$640.55K (1)

−$640.55K

1,870

0.0019%

$69.90K

−6.5%

Thomas Patrick Kelly

Chief Financial Officer

$559.74K (1)

—

+$559.74K

22,500

0.0232%

$841.05K

—

Andrea DiFabio

Chief Legal Officer

—

$230.81K (2) scheduled

−$230.81K

7,301

0.0075%

$272.91K

—

Gary Patou

Director

—

$70.25K (1) scheduled

−$70.25K

24,896

0.0257%

$930.61K

+5.6%

Gillian Cannon

Director

—

$63.24K (1) scheduled

−$63.24K

1,455

0.0015%

$54.39K

—

Dawn Svoronos

Director

—

31,373

0.0324%

$1.17M

+25.5%

Patrick Machado

Director

—

2,645

0.0027%

$98.87K

—

Justin D. Gover

Director

—

2,645

0.0027%

$98.87K

—

Elizabeth A. Garofalo

Director

—

2,645

0.0027%

$98.87K

—

Sherry Aulin

Chief Financial Officer

—

0.0000%

$0.00

—

Xenon Pharmaceuticals Inc.

What the insiders did Net buying

By person